SMEDEGAARDEN VVS & KLOAK ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.6% 6.4% 8.3% 5.4% 5.9%  
Credit score (0-100)  54 38 29 40 38  
Credit rating  BBB BBB BB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9

Net sales  0 0 0 0 0  
Gross profit  6,608 5,296 4,920 5,195 4,534  
EBITDA  563 262 62.6 475 109  
EBIT  433 100 -64.7 362 -75.5  
Pre-tax profit (PTP)  295.4 25.1 -60.0 390.8 -76.4  
Net earnings  249.8 5.3 -37.8 292.3 -53.2  
Pre-tax profit without non-rec. items  295 25.1 -60.0 391 -76.4  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9

Tangible assets total  405 542 455 626 559  
Shareholders equity total  998 1,009 972 1,264 1,011  
Interest-bearing liabilities  832 780 127 0.0 553  
Balance sheet total (assets)  4,083 4,199 4,020 4,018 3,775  

Net Debt  811 777 125 -61.5 530  
 
See the entire balance sheet

Volume 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  6,608 5,296 4,920 5,195 4,534  
Gross profit growth  -2.4% -19.9% -7.1% 5.6% -12.7%  
Employees  0 12 12 12 11  
Employee growth %  0.0% 0.0% 0.0% 0.0% -8.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,083 4,199 4,020 4,018 3,775  
Balance sheet change%  19.1% 2.8% -4.2% -0.1% -6.0%  
Added value  433.1 100.0 -64.7 361.9 -75.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -106 -65 -255 57 -251  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 -1.0 1.0 -1.0  

Profitability 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  6.6% 1.9% -1.3% 7.0% -1.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  11.8% 2.8% -0.5% 10.1% -1.2%  
ROI %  24.1% 6.2% -1.3% 33.0% -3.3%  
ROE %  28.6% 0.5% -3.8% 26.2% -4.7%  

Solidity 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Equity ratio %  28.1% 26.6% 24.2% 31.5% 26.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  144.0% 296.3% 199.1% -12.9% 485.2%  
Gearing %  83.3% 77.2% 13.0% 0.0% 54.7%  
Net interest  0 0 0 0 0  
Financing costs %  16.2% 11.3% 9.1% 26.3% 10.2%  

Liquidity 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Quick Ratio  1.0 0.9 0.9 0.9 0.8  
Current Ratio  1.2 1.2 1.1 1.2 1.1  
Cash and cash equivalent  20.8 3.1 1.9 61.5 23.0  

Capital use efficiency 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  673.8 506.0 424.4 610.9 377.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 8 -5 30 -7  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 22 5 40 10  
EBIT / employee  0 8 -5 30 -7  
Net earnings / employee  0 0 -3 24 -5